Atrial flutter with 1:1 conduction after administration of the antimalarial drug mefloquine

Clinical Cardiology

Volumn 19, Issue 12, 1996, Pages 967-968

  Fonteyne, Winoc ^a   Bauwens, Anja ^a   Jordaens, Luc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

antimalarial drugs; atrial flutter; atrial tachycardia; mefloquine

Indexed keywords

ANTIMALARIAL AGENT; MEFLOQUINE; QUINIDINE; QUININE;

ADULT; ARTICLE; ATRIOVENTRICULAR CONDUCTION; BRADYCARDIA; CARDIOTOXICITY; CASE REPORT; HEART ATRIUM FLUTTER; HEART PALPITATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALARIA; MALE; TREATMENT CONTRAINDICATION;

EID: 0029804601     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960191213     Document Type: Article

References (6)

1. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990;82:1106-1116
2. Olshansky B, Wilber D, Hariman R: Atrial flutter - update on the mechanism and treatment. PACE 1992;15:2308-2335
3. Moleiro F, Mendoza I, Medina-Ravell V, Castellanos A, Myerburg R: One-to-one atrioventricular conduction during atrial pacing at rates of 300/minute in absence of Wolff-Parkinson-White syndrome. Am J Cardiol 1981;48:789-795
4. Falk RH: Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992;117:141-150
5. McEvoy GMK: American Hospital Formulary Service Drug Information. American Society of Hospital Pharmacists. Edition 1992; 413-416
6. Palmer KJ, Holliday SM, Brogden RN: Mefloquine, a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993;45:430-475